3.50 (0.38%) Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on November 13, 2015, to consider the unaudited financial results for the quarter and half year ended September 30, 2015 (Q2) and related matters, and to fix record date for Sub-Division of 1 Equity Share of face value of Rs 10 each into 5 Equity Shares of Rs 2 Each. Further, the Company has informed that Trading Window for dealing in the securities of the Company will be closed from November 05, 2015 to November 15, 2015.
The above information is a part of company’s filings submitted to BSE.